Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

No longer available 1Completed 1

Sponsor Class

OTHER 13INDUSTRY 2NETWORK 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Fibrosis 2Carcinoma, Hepatocellular 2Liver Cirrhosis 1Hepatitis D 1Hepatitis B, Chronic 1Hepatitis B 1Esophageal and Gastric Varices 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Tenofovir × Clear all
NCT05683548 2025-02-17

RCAP

Replicor Inc.

No longer available
Gastrointestinal

Hepatitis D, Esophageal and Gastric Varices, Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡